Evidence map›Paper›PMID 38482617›Full record

ReviewCurrent Alzheimer research2024

Research Progress of Mitophagy in Alzheimer's Disease.

Jinglin Yao, Bohong Kan, Zhengjia Dong, Zhenyu Tang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current Alzheimer research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jinglin YaoFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.ORCID 0009-0002-6888-6074
Bohong KanFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.ORCID 0000-0003-0153-8243
Zhengjia DongFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.ORCID 0000-0001-9758-3967
Zhenyu TangFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.ORCID 0000-0002-2928-1016
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine · CN

Funding

National Natural Science Foundation of China (NSFC) 82074533Special Scientific Research Project of Integrated Traditional Chinese and Western Medicine of Tianjin Municipal Health Commission 2021015
6 · The paper itself

Abstract

The prevalence of Alzheimer's disease (AD) is increasing as the elderly population, which hurts elderly people's cognition and capacity for self-care. The process of mitophagy involves the selective clearance of ageing and impaired mitochondria, which is required to preserve intracellular homeostasis and energy metabolism. Currently, it has been discovered that mitophagy abnormalities are intimately linked to the beginning and progression of AD. This article discusses the mechanism of mitophagy, abnormal mitophagy, and therapeutic effects in AD. The purpose is to offer fresh perspectives on the causes and remedies of AD.

Indexed as

Alzheimer DiseaseMitophagyAnimalsHumansMitochondriaAlzheimer's disease (AD)homeostasis.mitochondrial damagemitophagyparkinPINK1

Identifiers

PMID38482617
OpenAlexW4392812060

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.